Managing the side effects of sodium-glucose cotransporter-2 inhibitors
Cleveland Clinic Journal of Medicine · 2025-08 · 92 (8) · 503-511
DOI: 10.3949/ccjm.92a.24071 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cleveland Clinic Journal of Medicine, online erschienen am 01.08.2025. Verfasst von Nandan Kodur und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Diabetes Mellitus, Type 2, Hypoglycemic Agents. Die Arbeit wurde bisher 17-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH.
- Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic, Cleveland, OH; mProfessor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH.
- Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH; Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH tangw@ccf.org.
Zitieren
APA
Kodur, N., Sharew, B., Lansang, M. C., & Tang, W. H. W. (2025). Managing the side effects of sodium-glucose cotransporter-2 inhibitors. Cleveland Clinic Journal of Medicine, 92(8), 503-511. https://doi.org/10.3949/ccjm.92a.24071
Vancouver
Kodur N, Sharew B, Lansang MC, Tang WHW. Managing the side effects of sodium-glucose cotransporter-2 inhibitors. Cleveland Clinic Journal of Medicine. 2025;92(8):503-511. doi:10.3949/ccjm.92a.24071
BibTeX
@article{Kodur2025,
author = {Kodur, Nandan and Sharew, Betemariam and Lansang, M Cecilia and Tang, W H Wilson},
title = {Managing the side effects of sodium-glucose cotransporter-2 inhibitors},
journal = {Cleveland Clinic Journal of Medicine},
year = {2025},
volume = {92},
number = {8},
pages = {503--511},
doi = {10.3949/ccjm.92a.24071}
}
EUVIMED